Malta - English - Medicines Authority

fair-med healthcare gmbh planckstr. 13, 22765 hamburg, germany - exemestane - film-coated tablet - exemestane 25 mg - endocrine therapy

Ireland - English - HPRA (Health Products Regulatory Authority)

actavis group ptc ehf - exemestane - film-coated tablet - 25 milligram(s) - aromatase inhibitors; exemestane

Ireland - English - HPRA (Health Products Regulatory Authority)

teva b.v. - exemestane - film-coated tablet - aromatase inhibitors; exemestane

Malta - English - Medicines Authority

h. lundbeck a.s. 9 ottiliavej, 2500 valby, copenhagen, denmark - nortriptyline hydrochloride - film-coated tablet - nortriptyline hydrochloride 10 mg - psychoanaleptics

Australia - English - Department of Health (Therapeutic Goods Administration)

cipla australia pty ltd - phenylephrine hydrochloride, quantity: 10 mg - tablet, film coated - excipient ingredients: purified talc; magnesium stearate; purified water; colloidal anhydrous silica; hyprolose; maize starch; microcrystalline cellulose; titanium dioxide; hypromellose; iron oxide red; macrogol 400 - for relief of blocked or runny noses

Australia - English - Department of Health (Therapeutic Goods Administration)

cipla australia pty ltd - phenylephrine hydrochloride, quantity: 10 mg - tablet, film coated - excipient ingredients: maize starch; colloidal anhydrous silica; purified water; magnesium stearate; hyprolose; purified talc; microcrystalline cellulose; titanium dioxide; hypromellose; iron oxide red; macrogol 400 - for relief of blocked or runny noses

Malta - English - Medicines Authority

remedica limited limassol industrial estate, aharnon street, 3056 limassol, cyprus - exemestane - film-coated tablet - exemestane 25 mg - endocrine therapy

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - exemestane, quantity: 25 mg - tablet, film coated - excipient ingredients: mannitol; polysorbate 80; microcrystalline cellulose; hypromellose; macrogol 400; colloidal anhydrous silica; titanium dioxide; magnesium stearate; sodium starch glycollate type a; crospovidone - exemestane sandoz is indicated for the sequential adjuvant treatment of oestrogen receptor-positive early breast cancer in post-menopausal women who have received prior adjuvant tamoxifen therapy.,exemestane sandoz is indicated for the treatment of oestrogen receptor-positive advanced breast cancer in women with natural or induced postmenopausal status whose disease has progressed following anti-oestrogen therapy.

Australia - English - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - exemestane, quantity: 25 mg - tablet, film coated - excipient ingredients: crospovidone; sodium starch glycollate type a; hypromellose; magnesium stearate; mannitol; microcrystalline cellulose; colloidal anhydrous silica; polysorbate 80; titanium dioxide; macrogol 400 - exemestane is indicated for the sequential adjuvant treatment of estrogen receptor-positive early breast cancer in post-menopausal women who have received prior adjuvant tamoxifen therapy. . exemestane is indicated for the treatment of estrogen receptor-positive advanced breast cancer in women with natural or induced postmenopausal status whose disease has progressed following anti-estrogen therapy.

Malta - English - Medicines Authority

h. lundbeck a.s. 9 ottiliavej, 2500 valby, copenhagen, denmark - nortriptyline hydrochloride - film-coated tablet - nortriptyline hydrochloride 25 mg - psychoanaleptics